News

STAT17h
Pharmalittle: We’re watching Europe moving to reject Elevidys, a FDA panel on SSRI risks, and more
European regulators on Friday said that the Duchenne muscular dystrophy gene therapy Elevidys should not be approved ...
GSK revenue hole raises chances of risky M&A move
CEO Emma Walmsley’s 40-bln-pound 2031 sales target looks fanciful after another disappointing drug trial. A healthy balance ...
Why Centene (CNC) Stock Is Trading Up Today
Shares of health coverage company Centene (NYSE:CNC) jumped 5.9% in the afternoon session after the company reported ...